Hepatotoxicity associated with the use of teriflunomide in a patient with multiple sclerosis: A case report

RATIONALE: Teriflunomide is an inhibitor of pyrimidine synthesis available as a first-line treatment for relapsing-remitting multiple sclerosis. Drug-induced liver damage is a relevant problem in clinical practice, representing a frequent cause of treatment discontinuation. This case report describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Cristiane Munaretto, de Vasconcelos-Pereira, Erica Freire, de Oliveira, Vanessa Marcon, Salgado, Pedro Rippel, Domingos, João Américo, Monreal, Maria Tereza Ferreira Duenhas, Guerra-Shinohara, Elvira Maria, Gubert, Vanessa Terezinha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701948/
https://www.ncbi.nlm.nih.gov/pubmed/34941096
http://dx.doi.org/10.1097/MD.0000000000028246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701948/
https://www.ncbi.nlm.nih.gov/pubmed/34941096
http://dx.doi.org/10.1097/MD.0000000000028246

Ejemplares similares